相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Exposure to Nicotine and Carcinogens among Southwestern Alaskan Native Cigarette Smokers and Smokeless Tobacco Users
Neal L. Benowitz et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2012)
Genetic variability in the metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL)
Monica Ter-Minassian et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
CYP2A6 and CYP2B6 genetic variation and its association with nicotine metabolism in South Western Alaska Native people
Matthew J. Binnington et al.
PHARMACOGENETICS AND GENOMICS (2012)
Urinary levels of the tobacco-specific carcinogen N'-nitrosonornicotine and its glucuronide are strongly associated with esophageal cancer risk in smokers
Jian-Min Yuan et al.
CARCINOGENESIS (2011)
Time Course of Nicotine and Cotinine Incorporation into Samples of Nonsmokers' Beard Hair Following a Single Dose of Nicotine Polacrilex*
John T. Bernert et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2011)
Relationship Between CYP2A6 and CHRNA5-CHRNA3-CHRNB4 Variation and Smoking Behaviors and Lung Cancer Risk
Catherine A. Wassenaar et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Comparison of Urine Cotinine and the Tobacco-Specific Nitrosamine Metabolite 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol (NNAL) and Their Ratio to Discriminate Active From Passive Smoking
Maciej Lukasz Goniewicz et al.
NICOTINE & TOBACCO RESEARCH (2011)
Racial Differences in the Relationship Between Number of Cigarettes Smoked and Nicotine and Carcinogen Exposure
Neal L. Benowitz et al.
NICOTINE & TOBACCO RESEARCH (2011)
Urine Menthol as a Biomarker of Mentholated Cigarette Smoking
Neal L. Benowitz et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Genetic Variation in Nicotine Metabolism Predicts the Efficacy of Extended-Duration Transdermal Nicotine Therapy
C. Lerman et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Hepatic CYP2A6 levels and nicotine metabolism: impact of genetic, physiological, environmental, and epigenetic factors
Nael Al Koudsi et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior
Thorgeir E. Thorgeirsson et al.
NATURE GENETICS (2010)
Utility and Relationships of Biomarkers of Smoking in African-American Light Smokers
Man Ki Ho et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Elimination Kinetics of the Tobacco-Specific Biomarker and Lung Carcinogen 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol
Maciej L. Goniewicz et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Urinary Levels of Tobacco-Specific Nitrosamine Metabolites in Relation to Lung Cancer Development in Two Prospective Cohorts of Cigarette Smokers
Jian-Min Yuan et al.
CANCER RESEARCH (2009)
Association of Nicotine Metabolite Ratio and CYP2A6 Genotype With Smoking Cessation Treatment in African-American Light Smokers
M. K. Ho et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Subpicogram per Milliliter Determination of the Tobacco-Specific Carcinogen Metabolite 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol in Human Urine Using Liquid Chromatography-Tandem Mass Spectrometry
Peyton Jacob et al.
ANALYTICAL CHEMISTRY (2008)
Extensive metabolic activation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in smokers
Irina Stepanov et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Smokers with the CHRNA Lung Cancer-Associated Variants Are Exposed to Higher Levels of Nicotine Equivalents and a Carcinogenic Tobacco-Specific Nitrosamine
Loic Le Marchand et al.
CANCER RESEARCH (2008)
Novel and established CYP2A6 alleles impair in vivo nicotine metabolism in a population of black African descent
Jill C. Mwenifumbo et al.
HUMAN MUTATION (2008)
CYP2A6 polymorphisms and risk for tobacco-related cancers
Ana Rossini et al.
PHARMACOGENOMICS (2008)
Genetic variability in CYP2A6 and the pharmacokinetics of nicotine
Jill C. Mwenifiumbo et al.
PHARMACOGENOMICS (2007)
Nicotine metabolism and CYP2A6 activity in a population of black African descent: Impact of gender and light smoking
Jill C. Mwenifumbo et al.
DRUG AND ALCOHOL DEPENDENCE (2007)
Relationship between machine-derived smoke yields and biomarkers in cigarette smokers in Germany
Gerhard Scherer et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2007)
An association of CYP2A6 genotype and smoking topography
Andrew A. Strasser et al.
NICOTINE & TOBACCO RESEARCH (2007)
CYP2A6 genotype and the metabolism and disposition kinetics of nicotine
Neal L. Benowitz et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Within-subject variation of the salivary 3HC/COT ratio in regular daily smokers: Prospects for estimating CYP2A6 enzyme activity in large-scale surveys of nicotine metabolic rate
Rod A. Lea et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2006)
Iqmik: A form of smokeless tobacco used among Alaska natives
CC Renner et al.
AMERICAN JOURNAL OF HEALTH BEHAVIOR (2005)
Ethnic variation in CYP2A6*7, CYP2A6*8 and CYP2A6*10 as assessed with a novel haplotyping method
JC Mwenifumbo et al.
PHARMACOGENETICS AND GENOMICS (2005)
Cytochrome p450 enzymes as catalysts of metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco specific carcinogen
JR Jalas et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2005)
Cytochrome P450 2A-catalyzed metabolic activation of structurally similar carcinogenic nitrosamines: N '-nitrosonornicotine enantiomers, N-nitrosopiperidine, and N-nitrosopyrrolidine
HL Wong et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2005)
Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult Caucasians
KA Schoedel et al.
PHARMACOGENETICS (2004)
Evaluation of CYP2A6 genetic polymorphisms as determinants of smoking behavior and tobacco-related lung cancer risk in male Japanese smokers
M Fujieda et al.
CARCINOGENESIS (2004)
Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity
D Dempsey et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Tobacco carcinogens, their biomarkers and tobacco-induced cancer
SS Hecht
NATURE REVIEWS CANCER (2003)